A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 43
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : Ad5
Long Form : Ad serotype 5
No. Year Title Co-occurring Abbreviation
2016 A Regulatory Element Near the 3' End of the Adeno-Associated Virus rep Gene Inhibits Adenovirus Replication in cis by Means of p40 Promoter-Associated Short Transcripts. AAV, AAV2, Ad, Pol II, RIS-Ad, TSS
2016 Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers. Ad6, Ads, PEG
2015 Characterization of an Oncolytic Adenovirus Vector Constructed to Target the cMet Receptor. Ads, HGF
2014 Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection. Ad5-gp83
2014 Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity. Ad, Ad
2013 Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. HD-Ad, IM, IVAG, Tcm
2013 Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation. Ad, KLRG1, LCMV
2012 Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells. Ad, Ad35, CAR, Carrier-F35, CRAd
2012 Mining the adenovirus "virome" for systemic oncolytics. Ads
10  2011 Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach. Ad
11  2011 Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic. Ad, CAR, CRAds, US, UTMD
12  2011 Mining the adenovirus virome for oncolytics against multiple solid tumor types. Ad
13  2011 Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge. Ad, Ad26, EBOV, GP
14  2010 Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35. Ad, Ad35, CD46TG, IL, mDCs, WT
15  2010 HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach. Ad, MPER
16  2010 Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy. Ad, CAR, DA, IHC, PD, SN, WT
17  2009 Adenovirus serotype 35 vector-mediated transduction following direct administration into organs of nonhuman primates. Ad
18  2009 Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver. Ad
19  2009 Technical note: a gene delivery system in the embryonic cells of avian species using a human adenoviral vector. Ad, GFP, mHIBCH, MyHC
20  2008 Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX. EM, pIX
21  2008 Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35. Ad, Ad35
22  2008 Efficient gene delivery in human and rodent mast cells using adenovirus vectors. Ad, Ad35, BMMCs, CD46TG, IgE, MCs
23  2008 [Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35]. Ad, Ad35, CAR
24  2007 Adenovirus vectors composed of subgroup B adenoviruses. Ad, CAR
25  2007 An effective method for adenoviral-mediated delivery of small interfering RNA into mesenchymal stem cells. Ad, MOIs, MSCs, siRNA
26  2007 Downregulation of human CD46 by adenovirus serotype 35 vectors. Ad
27  2006 Adenovirus vector-mediated gene transfer into stem cells. Ad, CAR, ES, HSCs, MSCs
28  2006 Photochemically enhanced adenoviral transduction in a multicellular environment. Ad, PCI, pDAMA
29  2006 Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells. AAV, Ad, CAR, DMD, hc, HV
30  2006 Typical and atypical trafficking pathways of Ad5 penton base recombinant protein: implications for gene transfer. Ad, PB
31  2006 [Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates]. Ad, Ad35, CAR
32  2005 Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Ad, EGFP, hMSCs
33  2005 Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins. Ad, FLS, RA, RGD, RGD, SF, WT
34  2005 Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons. Ad
35  2005 The influence of adenovirus fiber structure and function on vector development for gene therapy. Ads
36  2003 Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector. Ad, Ad35
37  2003 Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector. Ad, Ad35, CAR, GFP, HSCs
38  2002 Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines. Ad
39  2002 Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo. Ads, CAR
40  2000 Dependence of adenovirus infectivity on length of the fiber shaft domain. Ad, CAR
41  2000 Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development. Ad, HPV
42  1999 Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR. Ad, CAR
43  1998 New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Ad, PGK, RCAs